Cellular prion protein and NMDA receptor modulation: Protecting against excitotoxicity

Frontiers in Cell and Developmental Biology

Volumn 2, Issue AUG, 2014, Pages

  Black, Stefanie A G ^a,b   Stys, Peter K ^a,b   Zamponi, Gerald W ^a,b   Tsutsui, Shigeki ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Alzheimer's disease; Beta amyloid; Cellular prion protein; Excitotoxicity; Ischemia; Neuroinflammation; NMDA receptor

Indexed keywords

EID: 84971217304     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2014.00045     Document Type: Review

References (109)

1. Adle-Biassette, H., Verney, C., Peoc'h, K., Dauge, M. C., Razavi, F., Choudat, L., et al. (2006). Immunohistochemical expression of prion protein (PrPC) in the human forebrain during development. J. Neuropathol. Exp. Neurol. 65, 698-706. doi: 10.1097/01.jnen.0000228137.10531.72
2. Affaticati, P., Mignen, O., Jambou, F., Potier, M., Klingel-Schmitt, I., Degrouard, J., et al. (2011). Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cells. Cell Death Differ. 18, 99-108. doi: 10.1038/cdd.2010.79
3. Aguzzi, A., Baumann, F., and Bremer, J. (2008). The prion's elusive reason for being. Annu. Rev. Neurosci. 31, 439-477. doi: 10.1146/annurev.neuro.31.060407.125620
4. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G., et al. (2000). Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421. doi: 10.1016/S0197-4580(00)00124-X
5. Altmeppen, H. C., Prox, J., Puig, B., Dohler, F., Falker, C., Krasemann, S., et al. (2013). Roles of endoproteolytic alpha-cleavage and shedding of the prion protein in neurodegeneration. FEBS J. 280, 4338-4347. doi: 10.1111/febs.12196
6. Bailey, S., Carpentier, P., McMahon, E., Begolka, W., and Miller, S. (2006). Innate and adaptive immune responses of the central nervous system. Crit. Rev. Immunol. 26, 149-188. doi: 10.1615/CritRevImmunol.v26.i2.40
7. Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., et al. (2010). Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. U.S.A. 107, 2295-2300. doi: 10.1073/pnas.0911829107
8. Bartlett, T. E., and Wang, Y. T. (2013). The intersections of NMDAR-dependent synaptic plasticity and cell survival. Neuropharmacology 74, 59-68. doi: 10.1016/j.neuropharm.2013.01.012
9. Baumann, F., Tolnay, M., Brabeck, C., Pahnke, J., Kloz, U., Niemann, H. H., et al. (2007). Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J. 26, 538-547. doi: 10.1038/sj.emboj.7601510
10. Beland, M., Bedard, M., Tremblay, G., Lavigne, P., and Roucou, X. (2014). Abeta induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates. Neurobiol. Aging 35, 1537-1548. doi: 10.1016/j.neurobiolaging.2014.02.001
11. Beland, M., Motard, J., Barbarin, A., and Roucou, X. (2012). PrP(C) homodimerization stimulates the production of PrPC cleaved fragments PrPN1 and PrPC1. J. Neurosci. 32, 13255-13263. doi: 10.1523/JNEUROSCI.2236-12.2012
12. Bendheim, P., Brown, H., Rudelli, R., Scala, L., Goller, N., Wen, G., et al. (1992). Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42, 149-156. doi: 10.1212/WNL.42.1.149
13. Beraldo, F. H., Arantes, C. P., Santos, T. G., Machado, C. F., Roffe, M., Hajj, G. N., et al. (2011). Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin γ1 chain. FASEB J. 25, 265-279. doi: 10.1096/fj.10-161653
14. Beraldo, F. H., Arantes, C. P., Santos, T. G., Queiroz, N. G., Young, K., Rylett, R. J., et al. (2010). Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1. J. Biol. Chem. 285, 36542-36550. doi: 10.1074/jbc.M110.157263
15. Biasini, E., Turnbaugh, J. A., Unterberger, U., and Harris, D. A. (2012). Prion protein at the crossroads of physiology and disease. Trends Neurosci. 35, 92-103. doi: 10.1016/j.tins.2011.10.002
16. Biasini, E., Unterberger, U., Solomon, I. H., Massignan, T., Senatore, A., Bian, H., et al. (2013). A mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity. J. Neurosci. 33, 2408-2418. doi: 10.1523/JNEUROSCI.3406-12.2013
17. Boldyrev, A., Bryushkova, E., and Vladychenskaya, E. (2012). NMDA receptors in immune competent cells. Biochemistry (Mosc.) 77, 128-134. doi: 10.1134/S0006297912020022
18. Boldyrev, A., Carpenter, D., and Johnson, P. (2005). Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. J. Neurochem. 95, 913-918. doi: 10.1111/j.1471-4159.2005.03456.x
19. Bremer, J., Baumann, F., Tiberi, C., Wessig, C., Fischer, H., Schwarz, P., et al. (2010). Axonal prion protein is required for peripheral myelin maintenance. Nat. Neurosci. 13, 310-318. doi: 10.1038/nn.2483
20. Calella, A. M., Farinelli, M., Nuvolone, M., Mirante, O., Moos, R., Falsig, J., et al. (2010). Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol. Med. 2, 306-314. doi: 10.1002/emmm.201000082
21. Cappellano, G., Carecchio, M., Fleetwood, T., Magistrelli, L., Cantello, R., Dianzani, U., et al. (2013). Immunity and inflammation in neurodegenerative diseases. Am. J. Neurodegener. Dis. 2, 89-107
22. Carulla, P., Bribián, A., Rangel, A., Gavín, R., Ferrer, I., Caelles, C., et al. (2011). Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding. Mol. Biol. Cell 22, 3041-3054. doi: 10.1091/mbc.E11-04-0321
23. Cashman, N., Loertscher, R., Nalbantoglu, J., Shaw, I., Kascsak, R., Bolton, D., et al. (1990). Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 61, 185-192. doi: 10.1016/0092-8674(90)90225-4
24. Chatterton, J. E., Awobuluyi, M., Premkumar, L. S., Takahashi, H., Talantova, M., Shin, Y., et al. (2002). Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415, 793-798. doi: 10.1038/nature715
25. Chen, S., Yadav, S. P., and Surewicz, W. K. (2010). Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role of N-terminal residues. J. Biol. Chem. 285, 26377-26383. doi: 10.1074/jbc.M110.145516
26. Cisse, M., Sanchez, P. E., Kim, D. H., Ho, K., Yu, G. Q., and Mucke, L. (2011). Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J. Neurosci. 31, 10427-10431. doi: 10.1523/JNEUROSCI.1459-11.2011
27. Corlew, R., Brasier, D. J., Feldman, D. E., and Philpot, B. D. (2008). Presynaptic NMDA receptors: newly appreciated roles in cortical synaptic function and plasticity. Neuroscientist 14, 609-625. doi: 10.1177/1073858408322675
28. Cull-Candy, S. G., and Leszkiewicz, D. N. (2004). Role of distinct NMDA receptor subtypes at central synapses. Sci. STKE 2004:re16. doi: 10.1126/stke.2552004re16
29. Danysz, W., and Parsons, C. G. (2012). Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine-searching for the connections. Br. J. Pharmacol. 167, 324-352. doi: 10.1111/j.1476-5381.2012.02057.x
30. Enciu, A., and Popescu, B. (2013). Is there a causal link between inflammation and dementia? Biomed. Res. Int. 2013:316495. doi: 10.1155/2013/316495
31. Fleisch, V. C., Leighton, P. L., Wang, H., Pillay, L. M., Ritzel, R. G., Bhinder, G., et al. (2013). Targeted mutation of the gene encoding prion protein in zebrafish reveals a conserved role in neuron excitability. Neurobiol. Dis. 55, 11-25. doi: 10.1016/j.nbd.2013.03.007
32. Fluharty, B. R., Biasini, E., Stravalaci, M., Sclip, A., Diomede, L., Balducci, C., et al. (2013). An N-terminal fragment of the prion protein binds to amyloid-beta oligomers and inhibits their neurotoxicity in vivo. J. Biol. Chem. 288, 7857-7866. doi: 10.1074/jbc.M112.423954
33. Ford, M., Burton, L., Morris, R., and Hall, S. (2002). Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 113, 177-192. doi: 10.1016/S0306-4522(02)00155-0
34. Gadotti, V. M., Bonfield, S. P., and Zamponi, G. W. (2012). Depressive-like behaviour of mice lacking cellular prion protein. Behav. Brain. Res. 227, 319-323. doi: 10.1016/j.bbr.2011.03.012
35. Gadotti, V. M., and Zamponi, G. W. (2011). Cellular prion protein protects from inflammatory and neuropathic pain. Mol. Pain 7:59. doi: 10.1186/1744-8069-7-59
36. Ganor, Y., and Levite, M. (2012). 'Glutamate in the immune system: glutamate receptors in immune cells, potent effects, endogenous production and involvement in disease'. in Nerve-Driven Immunity, ed M. Levite (Wien: Springer-Verlag/Wien), 121-161. doi: 10.1007/978-3-7091-0888-8
37. Gill, S., and Pulido, O. (2001). Glutamate receptors in peripheral tissues: current knowledge, future research, and implications for toxicology. Toxicol. Pathol. 29, 208-223. doi: 10.1080/019262301317052486
38. Guillot-Sestier, M. V., Sunyach, C., Druon, C., Scarzello, S., and Checler, F. (2009). The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J. Biol. Chem. 284, 35973-35986. doi: 10.1074/jbc.M109.051086
39. Guillot-Sestier, M. V., Sunyach, C., Ferreira, S. T., Marzolo, M. P., Bauer, C., Thevenet, A., et al. (2012). alpha-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid beta (Abeta)-associated cell death. J. Biol. Chem. 287, 5021-5032. doi: 10.1074/jbc.M111.323626
40. Hardingham, G. E. (2009). Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem. Soc. Trans. 37, 1147-1160. doi: 10.1042/BST0371147
41. Hardingham, G. E., and Bading, H. (2010). Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682-696. doi: 10.1038/nrn2911
42. Heneka, M., O'banion, M., Terwel, D., and Kummer, M. (2010). Neuroinflammatory processes in Alzheimer's disease. J. Neural Transm. 117, 919-947. doi: 10.1007/s00702-010-0438-z
43. Hinoi, E., Takarada, T., Ueshima, T., Tsuchihashi, Y., and Yoneda, Y. (2004). Glutamate signaling in peripheral tissues. Eur. J. Biochem. 271, 1-13. doi: 10.1046/j.1432-1033.2003.03907.x
44. Hu, N. W., Nicoll, A. J., Zhang, D., Mably, A. J., O'Malley, T., Purro, S. A., et al. (2014). mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo. Nat. Commun. 5, 3374. doi: 10.1038/ncomms4374
45. Kahlfuß, S., Simma, N., Mankiewicz, J., Bose, T., Lowinus, T., Klein-Hessling, S., et al. (2014). Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells. Mol. Cell. Biol. 34, 820-831. doi: 10.1128/MCB.01273-13
46. Karadottir, R., Cavelier, P., Bergersen, L. H., and Attwell, D. (2005). NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438, 1162-1166. doi: 10.1038/nature04302
47. Kessels, H. W., Nguyen, L. N., Nabavi, S., and Malinow, R. (2010). The prion protein as a receptor for amyloid-beta. Nature 466, E3-E4. discussion: E4-E5. doi: 10.1038/nature09217
48. Khosravani, H., Zhang, Y., Tsutsui, S., Hameed, S., Altier, C., Hamid, J., et al. (2008). Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J. Cell Biol. 181, 551-565. doi: 10.1083/jcb.200711002
49. Kivisakk, P., Mahad, D., Callahan, M., Trebst, C., Tucky, B., Wei, T., et al. (2003). Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. U.S.A. 100, 8389-8394. doi: 10.1073/pnas.1433000100
50. Kleene, R., Loers, G., Langer, J., Frobert, Y., Buck, F., and Schachner, M. (2007). Prion protein regulates glutamate-dependent lactate transport of astrocytes. J. Neurosci. 27, 12331-12340. doi: 10.1523/JNEUROSCI.1358-07.2007
51. Klewpatinond, M., Davies, P., Bowen, S., Brown, D. R., and Viles, J. H. (2008). Deconvoluting the Cu2+ binding modes of full-length prion protein. J. Biol. Chem. 283, 1870-1881. doi: 10.1074/jbc.M708472200
52. Lai, T. W., Zhang, S., and Wang, Y. T. (2014). Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog. Neurobiol. 115, 157-188. doi: 10.1016/j.pneurobio.2013.11.006
53. Lau, A., and Tymianski, M. (2010). Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 460, 525-542. doi: 10.1007/s00424-010-0809-1
54. Lauren, J. (2014). Cellular prion protein as a therapeutic target in Alzheimer's disease. J. Alzheimers Dis. 38, 227-244. doi: 10.3233/JAD-130950
55. Lauren, J., Gimbel, D., Nygaard, H., Gilbert, J., and Strittmatter, S. (2009). Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128-1132. doi: 10.1038/nature07761
56. Li, J. B., Lu, Z. G., Xu, L., Wang, Q., Zhang, Z. H., and Fang, J. H. (2014). Neuroprotective effects of bis(7)-tacrine in a rat model of pressure-induced retinal ischemia. Cell Biochem. Biophys. 68, 275-282. doi: 10.1007/s12013-013-9707-4
57. Liu, T., Yi, W., Feng, B., Zhou, Z., and Xiao, G. (2013). IGF-1-induced enhancement of PRNP expression depends on the negative regulation of transcription factor FOXO3a. PLoS ONE 8:e71896. doi: 10.1371/journal.pone.0071896
58. Lynch, M. (2014). The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease. Immunology 141, 292-301. doi: 10.1111/imm.12156
59. Mabbott, N., Brown, K., Manson, J., and Bruce, M. (1997). T-lymphocyte activation and the cellular form of the prion protein. Immunology 92, 161-165. doi: 10.1046/j.1365-2567.1997.00331.x
60. Mayer, M. L. (2005). Glutamate receptor ion channels. Curr. Opin. Neurobiol. 15, 282-288. doi: 10.1016/j.conb.2005.05.004
61. Mayer, M. L., Vyklicky, L. Jr., and Clements, J. (1989). Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature 338, 425-427. doi: 10.1038/338425a0
62. McDonald, A. J., Dibble, J. P., Evans, E. G., and Millhauser, G. L. (2014). A new paradigm for enzymatic control of alpha-cleavage and beta-cleavage of the prion protein. J. Biol. Chem. 289, 803-813. doi: 10.1074/jbc.M113.502351
63. McLennan, N. F., Brennan, P. M., McNeill, A., Davies, I., Fotheringham, A., Rennison, K. A., et al. (2004). Prion protein accumulation and neuroprotection in hypoxic brain damage. Am. J. Pathol. 165, 227-235. doi: 10.1016/S0002-9440(10)63291-9
64. Micu, I., Jiang, Q., Coderre, E., Ridsdale, A., Zhang, L., Woulfe, J., et al. (2006). NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 439, 988-992. doi: 10.1038/nature04474
65. Mitsios, N., Saka, M., Krupinski, J., Pennucci, R., Sanfeliu, C., Miguel Turu, M., et al. (2007). Cellular prion protein is increased in the plasma and peri-infarcted brain tissue after acute stroke. J. Neurosci. Res. 85, 602-611. doi: 10.1002/jnr.21142
66. Mitteregger, G., Vosko, M., Krebs, B., Xiang, W., Kohlmannsperger, V., Nolting, S., et al. (2007). The role of the octarepeat region in neuroprotective function of the cellular prion protein. Brain Pathol. 17, 174-183. doi: 10.1111/j.1750-3639.2007.00061.x
67. Müller, W. E., Ushijima, H., Schroder, H. C., Forrest, J. M., Schatton, W. F., Rytik, P. G., et al. (1993). Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur. J. Pharmacol. 246, 261-267. doi: 10.1016/0922-4106(93)90040-G
68. Nicoll, A. J., Panico, S., Freir, D. B., Wright, D., Terry, C., Risse, E., et al. (2013). Amyloid-beta nanotubes are associated with prion protein-dependent synaptotoxicity. Nat. Commun. 4, 2416. doi: 10.1038/ncomms3416
69. Nieznanski, K., Choi, J. K., Chen, S., Surewicz, K., and Surewicz, W. K. (2012). Soluble prion protein inhibits amyloid-beta (Abeta) fibrillization and toxicity. J. Biol. Chem. 287, 33104-33108. doi: 10.1074/jbc.C112.400614
70. Ostapchenko, V. G., Beraldo, F. H., Guimaraes, A. L., Mishra, S., Guzman, M., Fan, J., et al. (2013). Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease. J. Neurochem. 127, 415-425. doi: 10.1111/jnc.12296
71. Paoletti, P., Bellone, C., and Zhou, Q. (2013). NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat. Rev. Neurosci. 14, 383-400. doi: 10.1038/nrn3504
72. Parsons, M. P., and Raymond, L. A. (2014). Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron 82, 279-293. doi: 10.1016/j.neuron.2014.03.030
73. Pina-Crespo, J. C., Talantova, M., Micu, I., States, B., Chen, H. S., Tu, S., et al. (2010). Excitatory glycine responses of CNS myelin mediated by NR1/NR3 'NMDA' receptor subunits. J. Neurosci. 30, 11501-11505. doi: 10.1523/JNEUROSCI.1593-10.2010
74. Qin, K., Yang, D. S., Yang, Y., Chishti, M. A., Meng, L. J., Kretzschmar, H. A., et al. (2000). Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP. Effect of protein age and deamidation. J. Biol. Chem. 275, 19121-19131. doi: 10.1074/jbc.275.25.19121
75. Quintanar, L., Rivillas-Acevedo, L., Grande-Aztatzi, R., Gómez-Castro, C. Z., Arcos-López, T., and Vela, A. (2013). Copper coordination to the prion protein: insights from theoretical studies. Coordin. Chem. Rev. 257, 429-444. doi: 10.1016/j.ccr.2012.06.026
76. Radovanovic, I., Braun, N., Giger, O. T., Mertz, K., Miele, G., Prinz, M., et al. (2005). Truncated prion protein and Doppel are myelinotoxic in the absence of oligodendrocytic PrPC. J. Neurosci. 25, 4879-4888. doi: 10.1523/JNEUROSCI.0328-05.2005
77. Rangel, A., Burgaya, F., Gavin, R., Soriano, E., Aguzzi, A., and Del Rio, J. A. (2007). Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis, and death: role of AMPA/kainate receptors. J. Neurosci. Res. 85, 2741-2755. doi: 10.1002/jnr.21215
78. Ratte, S., Vreugdenhil, M., Boult, J. K., Patel, A., Asante, E. A., Collinge, J., et al. (2011). Threshold for epileptiform activity is elevated in prion knockout mice. Neuroscience 179, 56-61. doi: 10.1016/j.neuroscience.2011.01.053
79. Resenberger, U. K., Harmeier, A., Woerner, A. C., Goodman, J. L., Muller, V., Krishnan, R., et al. (2011). The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO J. 30, 2057-2070. doi: 10.1038/emboj.2011.86
80. Riemer, C., Burwinkel, M., Schwarz, A., Gultner, S., Mok, S. W., Heise, I., et al. (2008). Evaluation of drugs for treatment of prion infections of the central nervous system. J. Gen. Virol. 89, 594-597. doi: 10.1099/vir.0.83281-0
81. Rubio-Perez, J., and Morillas-Ruiz, J. (2012). A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal 2012:756357. doi: 10.1100/2012/756357
82. Rush, T., and Buisson, A. (2014). Reciprocal disruption of neuronal signaling and Abeta production mediated by extrasynaptic NMDA receptors: a downward spiral. Cell Tissue Res. 356, 279-286. doi: 10.1007/s00441-013-1789-1
83. Sakurai-Yamashita, Y., Sakaguchi, S., Yoshikawa, D., Okimura, N., Masuda, Y., Katamine, S., et al. (2005). Female-specific neuroprotection against transient brain ischemia observed in mice devoid of prion protein is abolished by ectopic expression of prion protein-like protein. Neuroscience 136, 281-287. doi: 10.1016/j.neuroscience.2005.06.095
84. Salter, M. G., and Fern, R. (2005). NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438, 1167-1171. doi: 10.1038/nature04301
85. Schlief, M. L., West, T., Craig, A. M., Holtzman, D. M., and Gitlin, J. D. (2006). Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity. Proc. Natl. Acad. Sci. U.S.A. 103, 14919-14924. doi: 10.1073/pnas.0605390103
86. Shyu, W. C., Lin, S. Z., Chiang, M. F., Ding, D. C., Li, K. W., Chen, S. F., et al. (2005). Overexpression of PrPC by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model. J. Neurosci. 25, 8967-8977. doi: 10.1523/JNEUROSCI.1115-05.2005
87. Skerry, T., and Genever, P. (2001). Glutamate signalling in non-neuronal tissues. Trends Pharmacol. Sci. 22, 174-181. doi: 10.1016/S0165-6147(00)01642-4
88. Solito, E., and Sastre, M. (2012). Microglia function in Alzheimer's disease. Front. Pharmacol. 3:14. doi: 10.3389/fphar.2012.00014
89. Spudich, A., Frigg, R., Kilic, E., Kilic, U., Oesch, B., Raeber, A., et al. (2005). Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1. Neurobiol. Dis. 20, 442-449. doi: 10.1016/j.nbd.2005.04.002
90. Stanyon, H. F., Patel, K., Begum, N., and Viles, J. H. (2014). Copper(II) sequentially loads onto the N-terminal amino group of the cellular prion protein before the individual octarepeats. Biochemistry 53, 3934-3939. doi: 10.1021/bi500643b
91. Steele, A. D., Zhou, Z., Jackson, W. S., Zhu, C., Auluck, P., Moskowitz, M. A., et al. (2009). Context dependent neuroprotective properties of prion protein (PrP). Prion 3, 240-249. doi: 10.4161/pri.3.4.10135
92. Talantova, M., Sanz-Blasco, S., Zhang, X., Xia, P., Akhtar, M. W., Okamoto, S., et al. (2013). Abeta induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc. Natl. Acad. Sci. U.S.A. 110, E2518-E2527. doi: 10.1073/pnas.1306832110
93. Thakur, A. K., Srivastava, A. K., Srinivas, V., Chary, K. V., and Rao, C. M. (2011). Copper alters aggregation behavior of prion protein and induces novel interactions between its N-and C-terminal regions. J. Biol. Chem. 286, 38533-38545. doi: 10.1074/jbc.M111.265645
94. Thellung, S., Gatta, E., Pellistri, F., Corsaro, A., Villa, V., Vassalli, M., et al. (2013). Excitotoxicity through NMDA receptors mediates cerebellar granule neuron apoptosis induced by prion protein 90-231 fragment. Neurotox. Res. 23, 301-314. doi: 10.1007/s12640-012-9340-9
95. Tsutsui, S., Hahn, J., Johnson, T., Ali, Z., and Jirik, F. (2008). Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis. Am. J. Pathol. 173, 1029-1041. doi: 10.2353/ajpath.2008.071062
96. Tuneva, E., Bychkova, O., and Boldyrev, A. (2003). Effect of NMDA on production of reactive oxygen species by human lymphocytes. Bull. Exp. Biol. Med. 136, 159-161. doi: 10.1023/A:1026366907084
97. Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., et al. (2013). Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer αβ oligomer bound to cellular prion protein. Neuron 79, 887-902. doi: 10.1016/j.neuron.2013.06.036
98. Um, J. W., Nygaard, H. B., Heiss, J. K., Kostylev, M. A., Stagi, M., Vortmeyer, A., et al. (2012). Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat. Neurosci. 15, 1227-1235. doi: 10.1038/nn.3178
99. Walz, R., Amaral, O. B., Rockenbach, I. C., Roesler, R., Izquierdo, I., Cavalheiro, E. A., et al. (1999). Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 40, 1679-1682. doi: 10.1111/j.1528-1157.1999.tb01583.x
100. Wang, K. K., Zoltewicz, J. S., Chiu, A., Zhang, Z., and Rubenstein, R. (2012). Release of full-length PrP(C) from cultured neurons following neurotoxic challenges. Front. Neurol. 3:147. doi: 10.3389/fneur.2012.00147
101. Watt, N. T., Taylor, D. R., Kerrigan, T. L., Griffiths, H. H., Rushworth, J. V., Whitehouse, I. J., et al. (2012). Prion protein facilitates uptake of zinc into neuronal cells. Nat. Commun. 3, 1134. doi: 10.1038/ncomms2135
102. Weise, J., Crome, O., Sandau, R., Schulz-Schaeffer, W., Bahr, M., and Zerr, I. (2004). Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci. Lett. 372, 146-150. doi: 10.1016/j.neulet.2004.09.030
103. Weise, J., Doeppner, T. R., Muller, T., Wrede, A., Schulz-Schaeffer, W., Zerr, I., et al. (2008). Overexpression of cellular prion protein alters postischemic Erk1/2 phosphorylation but not Akt phosphorylation and protects against focal cerebral ischemia. Restor. Neurol. Neurosci. 26, 57-64
104. Weise, J., Sandau, R., Schwarting, S., Crome, O., Wrede, A., Schulz-Schaeffer, W., et al. (2006). Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke 37, 1296-1300. doi: 10.1161/01.STR.0000217262.03192.d4
105. Weller, R., Preston, S., Subash, M., and Carare, R. (2009). Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res. Ther. 1:6. doi: 10.1186/alzrt6
106. Wyllie, D. J., Livesey, M. R., and Hardingham, G. E. (2013). Influence of GluN2 subunit identity on NMDA receptor function. Neuropharmacology 74, 4-17. doi: 10.1016/j.neuropharm.2013.01.016
107. Xiao, B., and Link, H. (1998). Immune regulation within the central nervous system. J. Neurol. Sci. 157, 1-12. doi: 10.1016/S0022-510X(98)00049-5
108. You, H., Tsutsui, S., Hameed, S., Kannanayakal, T., Chen, L., Xia, P., et al. (2012). Abeta neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 109, 1737-1742. doi: 10.1073/pnas.1110789109
109. Younan, N. D., Klewpatinond, M., Davies, P., Ruban, A. V., Brown, D. R., and Viles, J. H. (2011). Copper(II)-induced secondary structure changes and reduced folding stability of the prion protein. J. Mol. Biol. 410, 369-382. doi: 10.1016/j.jmb.2011.05.013